CC-486 plus venetoclax: another step toward oral AML therapy.

Venclexta (venetoclax) - Roche, AbbVie

Onureg (azacitidine oral) - BMS

CC-486 plus venetoclax: another step toward oral AML therapy. (PubMed, Blood Adv) - Oct 1, 2026 - No abstract available
Journal • Acute Myelogenous Leukemia

http://www.ncbi.nlm.nih.gov/pubmed/42814506

Kimberly Seymour; Marina Konopleva

Oct 1, 2026